147 related articles for article (PubMed ID: 2015977)
1. Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice.
Surwit RS; Seldin MF; Kuhn CM; Cochrane C; Feinglos MN
Diabetes; 1991 Jan; 40(1):82-7. PubMed ID: 2015977
[TBL] [Abstract][Full Text] [Related]
2. Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice.
Ranheim T; Dumke C; Schueler KL; Cartee GD; Attie AD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3286-93. PubMed ID: 9409324
[TBL] [Abstract][Full Text] [Related]
3. A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice.
Kaku K; McGill J; Province M; Permutt MA
Diabetologia; 1989 Oct; 32(10):716-23. PubMed ID: 2574118
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice.
Coleman DL; Schwizer RW; Leiter EH
Diabetes; 1984 Jan; 33(1):26-32. PubMed ID: 6228478
[TBL] [Abstract][Full Text] [Related]
5. Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains.
Danciger M; Yang H; Ralston R; Liu Y; Matthes MT; Peirce J; Lavail MM
Mol Vis; 2007 Jan; 13():79-85. PubMed ID: 17277741
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity.
Plum L; Kluge R; Giesen K; Altmüller J; Ortlepp JR; Joost HG
Diabetes; 2000 Sep; 49(9):1590-6. PubMed ID: 10969845
[TBL] [Abstract][Full Text] [Related]
7. Molecular mapping of the mouse db mutation.
Bahary N; Leibel RL; Joseph L; Friedman JM
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8642-6. PubMed ID: 1978328
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control.
Kaku K; Province M; Permutt MA
Diabetologia; 1989 Sep; 32(9):636-43. PubMed ID: 2676665
[TBL] [Abstract][Full Text] [Related]
9. Allelic variation on chromosome 5 controls beta-cell mass expansion during hyperglycemia in leptin receptor-deficient diabetes mice.
Luo N; Liu SM; Liu H; Li Q; Xu Q; Sun X; Davis B; Li J; Chua S
Endocrinology; 2006 May; 147(5):2287-95. PubMed ID: 16484328
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control.
Kaku K; Fiedorek FT; Province M; Permutt MA
Diabetes; 1988 Jun; 37(6):707-13. PubMed ID: 3289991
[TBL] [Abstract][Full Text] [Related]
11. Developing a new model for non-insulin dependent diabetes mellitus (NIDDM) by using the Philippine wild mouse, Mus musculus castaneus.
Anunciado RV; Imamura T; Ohno T; Horio F; Namikawa T
Exp Anim; 2000 Jan; 49(1):1-8. PubMed ID: 10803355
[TBL] [Abstract][Full Text] [Related]
12. Diet-induced type II diabetes in C57BL/6J mice.
Surwit RS; Kuhn CM; Cochrane C; McCubbin JA; Feinglos MN
Diabetes; 1988 Sep; 37(9):1163-7. PubMed ID: 3044882
[TBL] [Abstract][Full Text] [Related]
13. Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait.
Mathews CE; Leiter EH
Diabetes; 1999 Nov; 48(11):2189-96. PubMed ID: 10535453
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus.
Mills E; Kuhn CM; Feinglos MN; Surwit R
Am J Physiol; 1993 Jan; 264(1 Pt 2):R73-8. PubMed ID: 8430889
[TBL] [Abstract][Full Text] [Related]
15. Myostatin inhibition therapy for insulin-deficient type 1 diabetes.
Coleman SK; Rebalka IA; D'Souza DM; Deodhare N; Desjardins EM; Hawke TJ
Sci Rep; 2016 Sep; 6():32495. PubMed ID: 27581061
[TBL] [Abstract][Full Text] [Related]
16. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.
Wicker LS; Miller BJ; Coker LZ; McNally SE; Scott S; Mullen Y; Appel MC
J Exp Med; 1987 Jun; 165(6):1639-54. PubMed ID: 3585250
[TBL] [Abstract][Full Text] [Related]
17. The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion.
Horio F; Teradaira S; Imamura T; Anunciado RV; Kobayashi M; Namikawa T; Niki I
Eur J Endocrinol; 2005 Dec; 153(6):971-9. PubMed ID: 16322404
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase: a putative locus for diet-induced hyperglycemia.
Seldin MF; Mott D; Bhat D; Petro A; Kuhn CM; Kingsmore SF; Bogardus C; Opara E; Feinglos MN; Surwit RS
J Clin Invest; 1994 Jul; 94(1):269-76. PubMed ID: 8040269
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of a new mouse model for non-insulin-dependent diabetes.
Kim JH; Sen S; Avery CS; Simpson E; Chandler P; Nishina PM; Churchill GA; Naggert JK
Genomics; 2001 Jun; 74(3):273-86. PubMed ID: 11414755
[TBL] [Abstract][Full Text] [Related]
20. The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex.
Leiter EH; Coleman DL; Hummel KP
Diabetes; 1981 Dec; 30(12):1029-34. PubMed ID: 7030828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
